Nostrum Laboratories is recalling Metformin HCl Extended Release Tablets because of NDMA above the acceptable daily intake limit. Nostrum Laboratories (Kansas City, MO) announced on Nov. 2, 2020 that ...
PRINCETON, N.J. & LONDON--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY), and AstraZeneca (NYSE: AZN) today announced that KOMBIGLYZE ™ XR (saxagliptin and metformin HCl extended-release), ...
Lupin Pharmaceuticals Inc. is voluntarily recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg to the consumer level. As part of the ongoing assessment and ...
One of the manufacturers of a Type 2 diabetes drug, Metformin Hydrochloride Extended-Release Tablets, extended its recall of its 500mg and 750 mg pills, the U.S. Food and Drug Administration reported ...
PRINCETON, N.J. & LONDON--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) approved KOMBIGLYZE ™ ...
The company is recalling one lot of Metformin HCl Extended Release Tablets, USP 750 mg (generic equivalent to Glucophage Tablets) because of nitrosamine impurities. Nostrum Laboratories, Inc.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) approved JANUMET ® XR ...
Nostrum Laboratories, Inc. is voluntarily recalling 2 (two) lots of Metformin HCl Extended Release Tablets, USP 500 mg to the consumer level. The Metformin HCl Extended Release Tablets, USP 500 mg ...
LINCOLNSHIRE, Ill., November 1, 2005 – Takeda Pharmaceuticals North America, Inc. today announced that ACTOplus met TM (pioglitazone HCl and metformin HCl) is now available by prescription in ...
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today ...
Two lots of a widely used type 2 diabetes medication, metformin, are being recalled due to possible contamination with a potentially cancer-causing compound. Metformin is designed to lower glucose ...
Dr. Reddy’s Laboratories Ltd. on Thursday announced its launch of Saxagliptin and Metformin Hydrochloride Extended-Release Tablets in the U.S. market. It is the generic version of KOMBIGLYZE XR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback